Team:ATOMS-Turkiye/deneme

From 2013.igem.org

(Difference between revisions)
 
(46 intermediate revisions not shown)
Line 3: Line 3:
<html>
<html>
-
    <script>
+
  <head>
-
      function openPage(pg){
+
  </head>
-
        item = $("#slideshow items").children("div").eq(pg-1);
+
  <script>
-
        content=$("#slideshow #right");
+
    function openPage(pg){
-
        content.fadeOut(200);
+
      item = $("#slideshow items").children("div").eq(pg-1);
-
        content.html(item.find("#text").html());
+
      content=$("#slideshow #right");
-
        content.fadeIn(200);
+
      content.stop();
-
        image = item.find("#image");
+
      content.fadeOut(200);
-
        image.css("position","relative");
+
      content.html(item.find("#text").html());
-
        imagebox = $("#slideshow").find( "#imagebox");
+
      content.fadeIn(200);
-
        imagebox.fadeOut(200);
+
      image = item.find("#image");
-
        //image.width(imagebox.width());
+
      image.css("position","relative");
-
        image.height(imagebox.height()-$("#pager").height());
+
      imagebox = $("#slideshow").find( "#imagebox");
-
        imagebox.html(image.clone());
+
      imagebox.stop(200);
-
        imagebox.fadeIn(200);
+
      imagebox.fadeOut(200);
-
      }
+
      //image.width(imagebox.width());
-
      function initSlideShow(a){
+
      image.height(imagebox.height());
-
        items=a.children("items");
+
      imagebox.html(image.clone());
-
        l = items.children("div").length;
+
      imagebox.fadeIn(200);
-
        pager = a.find("#pager");
+
    }
-
        pages="<ul class='slide-pager'>";
+
    function initSlideShow(a){
-
        for( i=1;i<=l;i++ )
+
      items=a.children("items");
-
          pages+="<li onclick='openPage("+i+");' ><a href=''>"+i+"</a></li> ";
+
      l = items.children("div").length;
-
        pager.html(pages);
+
      pager = a.find("#pager");
-
        openPage(1);
+
      pages="<ul class='slide-pager'>";
-
       }
+
      for( i=1;i<=l;i++ )
-
       $(document).ready(function(){
+
        pages+="<li onclick='openPage("+i+");' ><a href='#' class='no-action'>"+i+"</a></li> ";
-
        initSlideShow( $("#slideshow") );
+
      pages+="</ul>"
-
       
+
      pages = $(pages);
-
       });
+
      pages.children("li").hover(function(){openPage(parseInt($(this).text()));});
-
     </script>
+
      pager.html(pages);
 +
      openPage(1);
 +
    }
 +
   
 +
initBillboard=function (a){
 +
  a.find("li").first().addClass("rui-billboard-current");
 +
  a.find(".rui-billboard-button-prev").click(function(e){
 +
    b= a.find(".rui-billboard-current");
 +
    if(b.is(':animated'))
 +
       return;
 +
    b.css("left",0);
 +
    b.animate({
 +
        left: a.outerWidth(true)
 +
    },function(){$(this).removeClass("rui-billboard-current");});
 +
    b=b.prev("li");
 +
    if(b.length<1)
 +
    b=a.find("li").last();
 +
    b.addClass("rui-billboard-current");
 +
    b.css("left",-a.outerWidth(true));
 +
    b.animate({
 +
        left: 0
 +
    });
 +
  });
 +
  a.find(".rui-billboard-button-next").click(function(e){
 +
    b= a.find(".rui-billboard-current");
 +
    if(b.is(':animated'))
 +
       return;
 +
    b.stop();
 +
    b.css("left",0);
 +
    b.animate({
 +
        left: -a.outerWidth(true)
 +
    },function(){$(this).removeClass("rui-billboard-current");});
 +
    //b.removeClass("rui-billboard-current");
 +
    b=b.next("li");
 +
    if(b.length<1)
 +
    b=a.find("li").first();
 +
    b.stop();
 +
    b.addClass("rui-billboard-current");
 +
    b.css("left",a.outerWidth(true));
 +
    b.animate({
 +
    left: 0
 +
    });
 +
  });
 +
}
 +
    $(document).ready(function(){
 +
      initSlideShow( $("#slideshow") );
 +
       $(".no-action").click(function (e){e.preventDefault();return true;});
 +
      initBillboard( $(".rui-billboard"));
 +
     });
 +
 
 +
  </script>
<div style="margin:4em;"width:50%;>
<div style="margin:4em;"width:50%;>
<div id="slideshow" class="box" style="width:100%;height:300px;">
<div id="slideshow" class="box" style="width:100%;height:300px;">
Line 40: Line 90:
           <image id="image" src="https://static.igem.org/mediawiki/2013/6/66/Oncoli-diagram-2.jpg"  />
           <image id="image" src="https://static.igem.org/mediawiki/2013/6/66/Oncoli-diagram-2.jpg"  />
           <div id="text">
           <div id="text">
-
             <p class='infocard'>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Morbi quis diam et felis adipiscing molestie. Nam elit odio, ullamcorper quis vehicula quis, fermentum quis urna. Pellentesque ultrices, ante quis adipiscing consectetur, massa velit tempor est, vel condimentum odio turpis cursus risus. Mauris imperdiet elit ligula, quis sodales nulla elementum eget. Nulla in vestibulum orci, vitae blandit massa. Maecenas ac tellus sit amet sapien tincidunt posuere quis quis elit. Cras at tristique justo. Suspendisse sit amet tortor ultrices, accumsan magna et, molestie felis. Donec a enim nibh. Quisque id dolor semper, tempor purus consequat, dignissim turpis. Phasellus condimentum massa interdum porttitor mattis.</p>
+
             <p class='infocard'><b>Welcome to our model of Oncoli.</b><br/> The genetically engineered Nissle 1917 bacteria present in the lumen produce nanofactories which are responsible of recognizing and inducing the apoptosis mechanism of cancer cells.</p>
           </div>
           </div>
         </div>
         </div>
Line 46: Line 96:
           <image id="image" src="https://static.igem.org/mediawiki/2013/c/cb/Oncoli-diagram-3.jpg" />
           <image id="image" src="https://static.igem.org/mediawiki/2013/c/cb/Oncoli-diagram-3.jpg" />
           <div id="text">
           <div id="text">
-
             <p class='infocard'>Curabitur malesuada vulputate mi, non fermentum justo vestibulum eu. Quisque semper nulla erat, quis tristique massa gravida at. In hac habitasse platea dictumst. Nunc gravida ut ipsum at dapibus. Nunc scelerisque velit in mauris venenatis, id consequat nisl aliquam. Nunc fringilla mauris non mauris luctus dictum. Etiam vulputate posuere velit non fermentum. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Quisque sodales leo quam, eget condimentum ipsum sagittis in. Duis molestie, lectus vitae consectetur rhoncus, orci orci iaculis massa, et bibendum magna felis nec enim. Mauris vel arcu elementum, sagittis lorem in, malesuada magna. Mauris tincidunt vehicula luctus. Maecenas cursus semper diam.</p>
+
             <p class='infocard'>The nanofactory complex produced by our bacteria is formed by three parts. These are: Anti-EpCAM , Protein G and our enzymes Luxs-pfs and His-link-enzyme. These nanofactories are released from bacteria into the lumen via signal peptides. Once the Anti-EpCAM’s present on the nanofactories bind to the EpCAM antigens present on the surface of epithelial cells, the enzymes Luxs-pfs and His-link-enzyme present within the nanofactories begin to use SAH in the lumen to produce AI-2: Quorum sensing material. </p>
           </div>
           </div>
         </div>
         </div>
Line 52: Line 102:
           <image id="image" src="https://static.igem.org/mediawiki/2013/2/26/Oncoli-diagram-4.jpg" />
           <image id="image" src="https://static.igem.org/mediawiki/2013/2/26/Oncoli-diagram-4.jpg" />
           <div id="text">
           <div id="text">
-
             <p class='infocard'></p>
+
             <p class='infocard'>Compared to normal cells, EpCAM antigens are expressed 100 times more on a cancer cell. Therefore the concentration of bound nanofactories on a cancer cell is 100 times greater.</p>
           </div>
           </div>
         </div>
         </div>
Line 58: Line 108:
           <image id="image" src="https://static.igem.org/mediawiki/2013/5/52/Oncoli-diagram-6.jpg" />
           <image id="image" src="https://static.igem.org/mediawiki/2013/5/52/Oncoli-diagram-6.jpg" />
           <div id="text">
           <div id="text">
-
             <p class='infocard'></p>
+
             <p class='infocard'>The AI-2 substance produced in the lumen by our nanofactories act like a chemo-attractant which trigger our Nissle 1917 bacteria to motions toward the cancer cells via the quorum sensing technique.</p>
           </div>
           </div>
         </div>
         </div>
Line 64: Line 114:
           <image id="image" src="https://static.igem.org/mediawiki/2013/b/b2/Oncoli-diagram-7.jpg" />
           <image id="image" src="https://static.igem.org/mediawiki/2013/b/b2/Oncoli-diagram-7.jpg" />
           <div id="text">
           <div id="text">
-
             <p class='infocard'></p>
+
             <p class='infocard'>TAT-Apoptin: our killer protein is controlled by an inducible promoter called LsrR-lsrk. LsrR-lsrk is induced by AI-2 which is formed when our nanofactories bind to the cancer cells. Our bacteria build up around cancer cells and release our killer protein: TAT-Apoptin. </p>
           </div>
           </div>
         </div>
         </div>
Line 70: Line 120:
           <image id="image" src="https://static.igem.org/mediawiki/2013/5/58/Oncoli-diagram-11.jpg" />
           <image id="image" src="https://static.igem.org/mediawiki/2013/5/58/Oncoli-diagram-11.jpg" />
           <div id="text">
           <div id="text">
-
             <p class='infocard'></p>
+
             <p class='infocard'>The secreted TAT-APOPTIN complex, binds to the cancer cells and normal cells, penetrating into the membrane without causing any damage. When apoptin reaches a specific concentration in the cytoplasm of cancer cells, the period of apoptosis begins and the cancer cells are destroyed. However the normal cells remain unaffected as apoptin is cancer specific. </p>
           </div>
           </div>
         </div>
         </div>
       </items>
       </items>
-
       <div id="left" style="position:relative;float:left;width:50%;height:100%;">
+
       <div id="left" style="position:relative;float:left;width:57.7%;height:100%;">
         <div id="imagebox" style="position:relative;text-align:center;width:100%;height:100%;overflow:hidden;">
         <div id="imagebox" style="position:relative;text-align:center;width:100%;height:100%;overflow:hidden;">
           image here
           image here
Line 82: Line 132:
       </div>
       </div>
        
        
-
       <div class="boxin" style="float:left;width:50%;height:100%;background:#dfdfdf;overflow:hidden;">
+
       <div class="boxin" style="float:left;width:42.3%;height:100%;overflow:hidden;background: #233447;">
         <div id="right" style="width:100%;height:100%;">
         <div id="right" style="width:100%;height:100%;">
           content here
           content here
-
        </div>
 
       </div>
       </div>
     </div>
     </div>
-
</div>
+
  </div>
 +
  </div>
 +
 
 +
<div class="tourview" style="background:url('https://static.igem.org/mediawiki/2013/thumb/e/e3/Oncoli-tour-main.png/800px-Oncoli-tour-main.png');-webkit-background-size: cover;-moz-background-size: cover;-o-background-size: cover;background-size: cover;">
 +
  <div style="padding-left:130px;padding-right:170px;padding-left:130px;padding-top:100px;padding-bottom:55px;height:135px;">
 +
  <a href="/Team:ATOMS-Turkiye/Tour:1" title="Take a tour"></a>
 +
  <a href="/Team:ATOMS-Turkiye/Tour:2"></a>
 +
  <a href="/Team:ATOMS-Turkiye/Tour:3"></a>
 +
  <a href="/Team:ATOMS-Turkiye/Tour:4"></a>
 +
  </div>
 +
</div>
 +
 
 +
 
 +
 +
 
</html>
</html>
 +
 +
{{:Team:ATOMS-Turkiye/Sponsors}}

Latest revision as of 03:48, 5 October 2013

Welcome to our model of Oncoli.
The genetically engineered Nissle 1917 bacteria present in the lumen produce nanofactories which are responsible of recognizing and inducing the apoptosis mechanism of cancer cells.

The nanofactory complex produced by our bacteria is formed by three parts. These are: Anti-EpCAM , Protein G and our enzymes Luxs-pfs and His-link-enzyme. These nanofactories are released from bacteria into the lumen via signal peptides. Once the Anti-EpCAM’s present on the nanofactories bind to the EpCAM antigens present on the surface of epithelial cells, the enzymes Luxs-pfs and His-link-enzyme present within the nanofactories begin to use SAH in the lumen to produce AI-2: Quorum sensing material.

Compared to normal cells, EpCAM antigens are expressed 100 times more on a cancer cell. Therefore the concentration of bound nanofactories on a cancer cell is 100 times greater.

The AI-2 substance produced in the lumen by our nanofactories act like a chemo-attractant which trigger our Nissle 1917 bacteria to motions toward the cancer cells via the quorum sensing technique.

TAT-Apoptin: our killer protein is controlled by an inducible promoter called LsrR-lsrk. LsrR-lsrk is induced by AI-2 which is formed when our nanofactories bind to the cancer cells. Our bacteria build up around cancer cells and release our killer protein: TAT-Apoptin.

The secreted TAT-APOPTIN complex, binds to the cancer cells and normal cells, penetrating into the membrane without causing any damage. When apoptin reaches a specific concentration in the cytoplasm of cancer cells, the period of apoptosis begins and the cancer cells are destroyed. However the normal cells remain unaffected as apoptin is cancer specific.

image here

Sponsors

Oncoli-s-tozal.png Oncoli-s-sigma.jpg Oncoli-s-sentegen.png

Retrieved from "http://2013.igem.org/Team:ATOMS-Turkiye/deneme"